{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T02:42:01Z","timestamp":1725763321633},"publisher-location":"Boston, MA","reference-count":60,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781489972941"},{"type":"electronic","value":"9781489973054"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1991]]},"DOI":"10.1007\/978-1-4899-7305-4_27","type":"book-chapter","created":{"date-parts":[[2013,12,9]],"date-time":"2013-12-09T13:46:52Z","timestamp":1386596812000},"page":"171-176","source":"Crossref","is-referenced-by-count":1,"title":["The present status of therapy for patients with aggressive non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","author":[{"given":"Julie M.","family":"Vose","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"27_CR1","first-page":"248","volume":"1","author":"VT Devita","year":"1973","unstructured":"DeVita VT, Chabner B, Hubbard SP et al. Advanced diffuse histiocytic lymphoma, a potentially curable disease. Lancet 1973; 1: 248\u2013250.","journal-title":"Lancet"},{"key":"27_CR2","doi-asserted-by":"crossref","first-page":"1484L1493","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","volume":"38","author":"EM McKelvey","year":"1976","unstructured":"McKelvey EM, Gottlieb JA, Wilson HE et al. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484L1493.","journal-title":"Cancer"},{"key":"27_CR3","first-page":"759","volume":"49","author":"AT Skarin","year":"1977","unstructured":"Skarin AT, Rosenthal DS, Maloney WC et al. Combination chemotherapy of advanced non-Hodgkin\u2019s lymphoma with bleomycin, Adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP). Blood 1977; 49: 759\u2013770.","journal-title":"Blood"},{"key":"27_CR4","unstructured":"Longo DL, DeVita Jr, Duffey P et al. Randomized trial of ProMACE-MOPP v. ProMACE-CytaBOM in Stage II-IV aggressive non-Hodgkin\u2019s lymphoma. Proc Am Soc Clin Oncol 1987; 6: 206."},{"key":"27_CR5","first-page":"26","volume":"24","author":"P Klimo","year":"1987","unstructured":"Klimo P, Connors JM. Updated clinical experience with MACOP-B. Semin Hematol 1987; 24: 26\u201334.","journal-title":"Semin Hematol"},{"key":"27_CR6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/JCO.1986.4.2.147","volume":"4","author":"B Coiffier","year":"1986","unstructured":"Coiffier B, Bryon PA, Berger F et al. Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). J Clin Oncol 1986; 4: 147\u2013153.","journal-title":"J Clin Oncol"},{"key":"27_CR7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1200\/JCO.1988.6.3.425","volume":"6","author":"DB Boyd","year":"1988","unstructured":"Boyd DB, Coleman M, Papish SW et al. COPBLAM III: Infusional combination chemotherapy for diffuse large-cell lymphoma. J Clin Oncol 1988; 6: 425\u2013433.","journal-title":"J Clin Oncol"},{"key":"27_CR8","unstructured":"Rappaport H. Tumors of the hematopoietic system in Atlas of Tumor Pathology, section 3, Fasicle 8, Washington DC, UA Armed Forces Institute of Pathology, 1966."},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1365-2141.1975.tb00911.x","volume":"31","author":"K Lennert","year":"1975","unstructured":"Lennert K, Mohri N, Stein H et al. The histopathology of malignant lymphoma. Br J Haematol 1975; 31: 193\u2013203.","journal-title":"Br J Haematol"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","volume":"34","author":"RI Lukes","year":"1974","unstructured":"Lukes RI, Collins RD. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488\u20131503.","journal-title":"Cancer"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","volume":"49","author":"National Cancer Institute sponsored study of classification of non-Hodgkin\u2019s lymphomas. Summary and description of a Working Formulation for clinical usage","year":"1982","unstructured":"National Cancer Institute sponsored study of classification of non-Hodgkin\u2019s lymphomas. Summary and description of a Working Formulation for clinical usage. The non-Hodgkin\u2019s lymphoma Pathologic classification Project. Cancer 1982; 49: 2112\u20132135.","journal-title":"Cancer"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/1097-0142(19850101)55:1<91::AID-CNCR2820550115>3.0.CO;2-K","volume":"55","author":"NCI Non-Hodgkin\u2019s Classification Project Writing Committee","year":"1985","unstructured":"NCI Non-Hodgkin\u2019s Classification Project Writing Committee. Classification of non-Hodgkin\u2019s lymphomas. Reproducibility of major classification systes. Cancer 1985; 55: 91\u201395.","journal-title":"Cancer"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/hon.2900030105","volume":"3","author":"SH Levitt","year":"1985","unstructured":"Levitt SH, Lee CR, Bloomfield CP et al. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol 1985; 3: 33\u201337.","journal-title":"Hematol Oncol"},{"key":"27_CR14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.1985.3.10.1309","volume":"3","author":"EE Vokes","year":"1985","unstructured":"Vokes EE, Ultman JE, Golomb HM et al. Long-term survival of patients with localized diffuse histiocytic lymphoma. J Clin Oncol 1985; 3: 1309\u20131317.","journal-title":"J Clin Oncol"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M","volume":"52","author":"NI Nisson","year":"1983","unstructured":"Nisson NI, Ersboll J, Hansen HS et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in Stage I-II non-Hodgkin\u2019s lymphomas. Cancer 1983; 52: 1\u20138.","journal-title":"Cancer"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0167-8140(84)80072-9","volume":"2","author":"P Carde","year":"1984","unstructured":"Carde P, Burgers IMV, van Glabbekem M et al. Combined radiotherapy-chemotherapy for early stage non-Hodgkin\u2019s lymphoma. Radiotherapy Oncology 1984; 2: 301\u2013304.","journal-title":"Radiotherapy Oncology"},{"key":"27_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood.V62.2.413.413","volume":"62","author":"TP Miller","year":"1983","unstructured":"Miller TP, Jones SE. Initial chemotherapy for clinically localized lymphoma of unfavorable histology. Blood 1983; 62: 413\u2013418.","journal-title":"Blood"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/0003-4819-107-1-25","volume":"107","author":"JM Connors","year":"1987","unstructured":"Connors JM, Klimo P, Fairey RN et al. Brief chemotherapy and involved field radiation therapy for limited stage, histologically aggressive lymphoma. Ann Intern Med 1987; 107: 25\u201330.","journal-title":"Ann Intern Med"},{"key":"27_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.1985.3.1.39","volume":"3","author":"S Jagannath","year":"1985","unstructured":"Jagannath S, Valasquez WS, Tucker SL et al. Stage IV diffuse large cell lymphoma: a long-term analysis. J Clin Oncol 1985; 3: 39\u201345.","journal-title":"J Clin Oncol"},{"key":"27_CR20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1986.4.3.295","volume":"4","author":"DO Dixon","year":"1986","unstructured":"Dixon DO, Neilan B, Jones JE et al. Effect of ages on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295\u2013305.","journal-title":"J Clin Oncol"},{"key":"27_CR21","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1200\/JCO.1988.6.11.1708","volume":"6","author":"U Tirelli","year":"1988","unstructured":"Tirelli U, Zagonel V, Serraino J et al. Non-Hodgkin lymphomas in 137 patients ages 70 or older: A Retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study. J Clin Oncol 1988; 6: 1708\u20131713.","journal-title":"J Clin Oncol"},{"key":"27_CR22","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1200\/JCO.1988.6.12.1838","volume":"6","author":"JM Vose","year":"1988","unstructured":"Vose JM, Armitage JO, Weisenburger DD et al. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 1988; 6: 1838\u20131844.","journal-title":"J Clin Oncol"},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/bjc.1985.258","volume":"52","author":"RK Ross","year":"1985","unstructured":"Ross RK, Dworsky RL, Paganini-Hill A et al. Non-Hodgkin\u2019s lymphoma in never married men in Los Angeles. Br J Cancer 1985; 52: 785\u2013787.","journal-title":"Br J Cancer"},{"key":"27_CR24","first-page":"41","volume":"1","author":"AM Levine","year":"1987","unstructured":"Levine AM, Gill PS. AIDS related malignant lymphoma: Clinical presentation and treatment approaches. Oncology 1987; 1: 41\u201346.","journal-title":"Oncology"},{"key":"27_CR25","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1200\/JCO.1987.5.9.1322","volume":"5","author":"PS Gill","year":"1987","unstructured":"Gill PS, Levine AM, Kraib M et al. AIDS-related malignant lymphoma: results of progressive treatment trials. J Clin Oncol 1987; 5: 1322\u20131328.","journal-title":"J Clin Oncol"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","volume":"108","author":"DM Knowles","year":"1988","unstructured":"Knowles DM, Chamulak GA, Subar M et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108: 744\u2013753.","journal-title":"Ann Intern Med"},{"key":"27_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/0002-9343(89)90232-5","volume":"86","author":"MA Barmudez","year":"1989","unstructured":"Barmudez MA, Grant KM, Rodvien R et al. Non-Hodgkin\u2019s lymphoma in a population with or at risk for acquired immunodeficiency syndrome: Indications for intensive chemotherapy. Am J Med 1989; 86: 71\u201376.","journal-title":"Am J Med"},{"key":"27_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.410200503","volume":"20","author":"YT So","year":"1986","unstructured":"So YT, Beckstead JHY, Davis PL. Primary central nervous system lymphoma in acquired immunodeficiency syndrome: A clinical and pathological study. Ann Neurol 1986; 20: 566\u2013572.","journal-title":"Ann Neurol"},{"key":"27_CR29","unstructured":"Barcos MP, Lukes RJ. Malignant lymnphoma of convoluted lymphocytes - A new entity of possible T-cell type. In: Sinus LF, Godden JO (eds). Conflicts in childhood cancer. An evaluation of current management, Vol. 4, New York Liss, p 147, 1975."},{"key":"27_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/1097-0142(197608)38:2<964::AID-CNCR2820380248>3.0.CO;2-V","volume":"38","author":"BN Nathwani","year":"1976","unstructured":"Nathwani BN, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic. Cancer 1976; 38: 964\u2013983.","journal-title":"Cancer"},{"key":"27_CR31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1182\/blood.V61.1.92.92","volume":"61","author":"AM Levine","year":"1983","unstructured":"Levine AM, Forman SJ, Meyer PR et al. Successful therapy of convoluted T-lymphoblastic lymphoma in adults. Blood 1983; 61: 92\u201398.","journal-title":"Blood"},{"key":"27_CR32","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1002\/1097-0142(19800615)45:12<3034::AID-CNCR2820451226>3.0.CO;2-7","volume":"45","author":"N Wollner","year":"1980","unstructured":"Wollner N, Wachtel AE, Exelby PR et al. Improved prognosis in children with intra-abdominal non-Hodgkin\u2019s lymphoma following LSA2\u2013L2 protocol chemotherapy. Cancer 1980; 45: 3034\u20133039.","journal-title":"Cancer"},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1200\/JCO.1986.4.6.847","volume":"4","author":"JI Bernstein","year":"1986","unstructured":"Bernstein JI, Coleman N, Strickelr JG et al. Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt\u2019s and non-Burkitt\u2019s type). J Clin Oncol 1986; 4: 847\u2013858.","journal-title":"J Clin Oncol"},{"key":"27_CR34","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood.V67.6.1578.1578","volume":"67","author":"SJ Horning","year":"1582","unstructured":"Horning SJ, Weiss CL, Crabtree CG et al. Clinical and phenotypic diversity of T-cell lymphomas. Blood 1986; 67: 1578\u20131582.","journal-title":"Blood"},{"key":"27_CR35","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1200\/JCO.1988.6.7.1088","volume":"6","author":"M Simoyama","year":"1988","unstructured":"Simoyama M, Ota K, Kikuchi M et al. Major prognostic factors of adult patients with advanced T-cell lymphoma\/leukemia. J Clin Oncol 1988; 6: 1088\u20131097.","journal-title":"J Clin Oncol"},{"key":"27_CR36","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1200\/JCO.1988.6.10.1584","volume":"6","author":"B Coiffier","year":"1988","unstructured":"Coiffier B, Berger F, Byron P-A et al. T-cell lymphomas; Immunologic, histologic, clinical and therapeutic analysis of 63 cases. J Clin Oncol 1988; 6: 1584\u20131589.","journal-title":"J Clin Oncol"},{"key":"27_CR37","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1200\/JCO.1989.7.12.1783","volume":"7","author":"JO Armitage","year":"1989","unstructured":"Armitage JO, Vose JM, Linder J et al. Clinical significance of immunophenotype in diffuse aggressive non-Hodgkin\u2019s lymphoma. J Clin Oncol 1989; 7: 1783\u20131790.","journal-title":"J Clin Oncol"},{"key":"27_CR38","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/1097-0142(197610)38:4<1484::AID-CNCR2820380407>3.0.CO;2-I","volume":"38","author":"EM Mckelveny","year":"1976","unstructured":"McKelveny EM, Gottlieb JA, Wilson HE et al. Hydroxyldaunomycin (Adriamycin) combiantion chemotherapy in malignant lymphoma. Cancer 1976; 38: 1484\u20131493.","journal-title":"Cancer"},{"key":"27_CR39","first-page":"197","volume":"5","author":"CA Coltman","year":"1986","unstructured":"Coltman CA, Jr., Dahlberg S, Jones SE et al. CHOP is curative in thirty percent of patients with large cell lymphoma: A twelve-year Southwest Oncology Group follow-up. Proc Am Soc Clin Oncol 1986 (abstr); 5: 197.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"27_CR40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0002-9343(77)90230-3","volume":"63","author":"RI Fisher","year":"1977","unstructured":"Fisher RI, DeVita VT, Johnson BL et al. Prognostic factors for advanced diffuse histiocytic lymphoma following treatment with combination chemotherapy. Am J Med 1977; 63: 177\u2013182.","journal-title":"Am J Med"},{"key":"27_CR41","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1200\/JCO.1986.4.3.295","volume":"4","author":"DO Dixon","year":"1986","unstructured":"Dixon DO, Neilan B, Jones JE et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295\u2013305.","journal-title":"J Clin Oncol"},{"key":"27_CR42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/0360-3016(86)90068-4","volume":"12","author":"MB Todd","year":"1986","unstructured":"Todd MB, Portlock CS, Farber LR et al. Prognostic indicators in diffuse large-cell histiocytic lymphoma. Int J Radiat Oncol Biol Phys 1986; 12: 593\u2013601.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"27_CR43","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/1097-0142(19821101)50:9<1695::AID-CNCR2820500907>3.0.CO;2-H","volume":"50","author":"JO Armitage","year":"1982","unstructured":"Armitage JO, Dick FR, Corder MP et al. Predicting therapeutic outcome in patients with diffuse histiocytic lymphoma treated with cyclophosphamide, Adriamycin, vincristine, and prednisone (CHOP). Cancer 1982; 50: 1695\u20131702.","journal-title":"Cancer"},{"key":"27_CR44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.1986.4.6.859","volume":"4","author":"S Jagannath","year":"1986","unstructured":"Jagannath S, Valasquez WS, Tucker SL et al. Tumor burden assessment and its implication for a prognostic model in advanced diffuse large cell lymphoma. J Clin Oncol 1986; 4: 859\u2013865.","journal-title":"J Clin Oncol"},{"key":"27_CR45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1200\/JCO.1983.1.2.91","volume":"1","author":"AT Skarin","year":"1983","unstructured":"Skarin AT, Conellos GP, Rosenthal DS et al. Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high-dose methotrexate alternating with standard agents (M-BACOD). J Clin Oncol 1983; 1: 91\u201398.","journal-title":"J Clin Oncol"},{"key":"27_CR46","first-page":"2","volume":"24","author":"GP Canellos","year":"1987","unstructured":"Canellos GP, Skarin AT, Klatt MM et al. The m-BACOD combination chemotherapy regimen in the treatment of diffuse large-cell lymphoma. Semin Hematol 1987; 24: 2\u20137.","journal-title":"Semin Hematol"},{"key":"27_CR47","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7326\/0003-4819-102-5-596","volume":"102","author":"P Klimo","year":"1985","unstructured":"Klimo P, Connors JM. MACOP-B chemotherapy for the treatment of advanced diffuse large-cell lymphoma. Ann Intern Med 1985; 102: 596\u2013602.","journal-title":"Ann Intern Med"},{"key":"27_CR48","unstructured":"Gordon LI, Harrington D, Glick JH et al. Randomized Phase IH comparison of CHOP versus m-BACOD in diffuse large cell and diffuse mixed lymphoma: Equivalent complete remission and time to treatment failure but greater toxicity with m-BACOD. Proc Am Soc Clin Oncol 1989 (Abstr); 8: 255."},{"key":"27_CR49","first-page":"17","volume":"25","author":"TP Miller","year":"1988","unstructured":"Miller TP, Dana BW, Weick JK et al. Southwest Oncology Group Clinical trials for intermediate and high-grade non-Hodgkin\u2019s lymphoma. Semin. Hematol 1988; 25: 17\u201322.","journal-title":"Semin. Hematol"},{"key":"27_CR50","first-page":"439","volume":"66","author":"JH Goldie","year":"1982","unstructured":"Goldie JH, Coldman AJ, Gudauskas GA. Rationale for the use of alternating non-cross resistant chemotherapy. Cancer Treat Rep 1982; 66: 439\u2013449.","journal-title":"Cancer Treat Rep"},{"key":"27_CR51","first-page":"206","volume":"6","author":"D Longo","year":"1987","unstructured":"Longo D, DeVita VT Jr, Duffey P et al. Randomized trial of ProMACE-MOPP (Day 1, D8) PM vs. ProMACE-CytaBOM (PC) in Stage II-IV aggressive Non-Hodgkin\u2019s lymphoma. Proc Am Soc Clin Oncol 1987 (Abstr); 6: 206.","journal-title":"Proc Am Soc Clin Oncol"},{"key":"27_CR52","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-104-3-338","volume":"104","author":"MJ Browne","year":"1986","unstructured":"Browne MJ, Hubbard SM, Longo DL et al. Excess prevalence of pneumocytis carinii pneumonia in patients treated for lymphoma with combination chemotherapy. Ann Intern Med 1986; 104: 338\u2013344.","journal-title":"Ann Intern Med"},{"key":"27_CR53","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood.V70.5.1394.1394","volume":"70","author":"B Coiffier","year":"1987","unstructured":"Coiffier B, Bryon PA, French M et al. Intensive chemotherapy in aggressive lymphomas: Updated results of LNH-80 Protocol and Prognostic Factors affecting response and survival. Blood 1987; 70: 1394\u20131399.","journal-title":"Blood"},{"key":"27_CR54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1200\/JCO.1987.5.3.407","volume":"5","author":"F Cabanillas","year":"1987","unstructured":"Cabanillas F, Hagemeister FB, McLaughlin P et al. Results of MIME regimen for recurrent or refractory lymphoma. J Clin Oncol 1987; 5: 407\u2013412.","journal-title":"J Clin Oncol"},{"key":"27_CR55","first-page":"61","volume":"36","author":"H Hagberg","year":"1986","unstructured":"Hagberg H, Cavallin-Stahl E, Lind J. Ifosfamide and etoposide as salvage therapy for non-Hodgkin\u2019s lymphoma. Scand J Haematol 1986; 36: 61\u201364.","journal-title":"Scand J Haematol"},{"key":"27_CR56","doi-asserted-by":"crossref","unstructured":"Velasquez WS, Cabanillas F, Salvador P et al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP). Blood 1988\u201371: 117\u2013122.","DOI":"10.1182\/blood.V71.1.117.bloodjournal711117"},{"key":"27_CR57","first-page":"187","volume":"71","author":"MR O\u2019Donnell","year":"1987","unstructured":"O\u2019Donnell MR, Forman SJ, Levine AM et al. Cytarabine, cisplatin and etoposide chemotherapy for refractory non-Hodgkin\u2019s lymphoma. Cancer Treat Rep 1987; 71: 187\u2013189.","journal-title":"Cancer Treat Rep"},{"key":"27_CR58","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1002\/1097-0142(19830601)51:11<1982::AID-CNCR2820511104>3.0.CO;2-L","volume":"51","author":"RP Warrell","year":"1983","unstructured":"Warrell RP, Coonley CJ, Straus DJ et al. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a sevenday continuous infusion. Cancer 1983; 51: 1982\u20131987.","journal-title":"Cancer"},{"key":"27_CR59","first-page":"783","volume":"69","author":"SR Helms","year":"1985","unstructured":"Helms SR, Oblon DJ, Braylan RC et al. Etoposide, carmustine, bleomycin and methotrexate with leucovorin rescue as retreat-ment for unfavorable non-Hodgkin\u2019s lymphoma. Cancer Treat Rep 1985; 69: 783\u2013786.","journal-title":"Cancer Treat Rep"},{"key":"27_CR60","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma. N Engl J Med 1987; 316: 1493\u20131498.","journal-title":"N Engl J Med"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-7305-4_27","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T20:07:41Z","timestamp":1597176461000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-7305-4_27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991]]},"ISBN":["9781489972941","9781489973054"],"references-count":60,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-7305-4_27","relation":{},"subject":[],"published":{"date-parts":[[1991]]}}}